ADVANCED MALIGNANT NEOPLASM
Clinical trials for ADVANCED MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Zapping liver tumors: new device trial for tough cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of combining standard chemotherapy drugs with a portable device that uses electrical fields to try to stop cancer growth. It is for patients whose cancer has spread to the liver and has not responded to other treatments. …
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Early trial tests new drug mixes for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Targeted pill trial offers hope for tough cancers with genetic flaw
Disease control OngoingThis study is testing an oral medication called talazoparib for people with advanced cancers that have spread, returned, or stopped responding to standard treatments. It is specifically for patients whose cancers have certain genetic changes in the BRCA pathway (like BRCA1, BRCA2…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug trial targets rare joint tumor and advanced cancers
Disease control OngoingThis study is testing an experimental drug called vimseltinib in adults with advanced solid tumors or a rare joint tumor called tenosynovial giant cell tumor (TGCT). The first phase aims to find the safest and most effective dose. The second phase will focus on TGCT patients to s…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Calming the storm: new hope for cancer patients in distress
Symptom relief OngoingThis study tests different medication approaches to calm severe agitation and confusion (delirium) in advanced cancer patients receiving palliative care. Researchers compare three strategies for patients who haven't responded to initial low-dose treatment: increasing the standard…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
Drug and exercise combo tested to fight debilitating cancer fatigue
Symptom relief OngoingThis study aims to see if a combination of a stimulant medication (methylphenidate) and a guided exercise program can reduce severe, cancer-related fatigue in patients with advanced or metastatic cancer who are receiving a type of immunotherapy. It will enroll about 212 adults wh…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Can a week of steroids and exercise beat debilitating cancer fatigue?
Symptom relief OngoingThis study is testing whether combining physical activity with a short course of the steroid dexamethasone can reduce severe fatigue in people with advanced cancer. It enrolled 90 participants to compare a high-dose steroid week with a low-dose steroid week, both alongside a 4-we…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
Needle to the spine offers hope for unbearable cancer pain
Symptom relief OngoingThis study is testing a procedure called cordotomy to see if it can reduce severe pain in people with advanced cancer when other pain treatments haven't worked. Doctors use a needle guided by a CT scan to interrupt pain signals in the spinal cord. The goal is to see if this provi…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Cancer patients asked: exam room or waiting room?
Knowledge-focused OngoingThis study aims to understand the preferences of advanced cancer patients and their caregivers regarding where they wait during outpatient palliative care visits. Researchers want to know if patients and caregivers prefer to go directly to an exam room or wait in a common waiting…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Can a simple question sheet improve doctor talks for cancer patients?
Knowledge-focused OngoingThis study is testing two different information sheets to see which one helps patients with advanced cancer and their caregivers communicate better with their doctors. It involves 207 patients, their caregivers, and their palliative care physicians. The goal is to see if a specif…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Cancer's hidden cost: study probes financial ruin for patients
Knowledge-focused OngoingThis study aims to understand how common and severe financial distress is for people with advanced cancer. Researchers are asking 141 patients to complete short surveys about their financial situation, symptoms, and quality of life. The goal is to learn how the high cost of cance…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC